Riskpilot← Back to searchSign inGet full accessNaprapatEliten Norrköping AB
ABActiveOrg 5593554438Lundatorpsvägen 3Physiotherapy activities · NACE 8695Est. 20215-9 employees
Revenue 2025
SEK 4,6M
+20% vs 2024
EBITDA margin
11.9%
+198% vs 2024
Equity ratio
30.2%
Financial strength
Net profit 2025
SEK 379K
+334% vs 2024
| Revenue | SEK 4,6M | +20% |
| EBITDA | SEK 543K | +198% |
| Net profit | SEK 379K | +334% |
| Total assets | SEK 1,5M | +41% |
| Equity | SEK 453K | +513% |
| Employees | — | — |
Legal name
NaprapatEliten Norrköping AB
Org number
5593554438
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
20 december 2021
Share capital
SEK 25 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Föremålet för bolagets verksamhet är att bedriva friskvård, hälsovård, naprapatklinik och därmed förenlig verksamhet.
Address
Lundatorpsvägen 3
Email
olle@naprapateliten.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 880 | 3 696 | 3 787 | 4 555 |
| Staff expenses | — | −2 570 | −2 739 | −3 086 |
| EBITDA | −55 | 85 | 182 | 543 |
| Depreciation & amort. | −13 | −28 | −48 | −55 |
| EBIT | −68 | 57 | 135 | 487 |
| Net financials | −10 | −17 | −18 | −4 |
| Profit before tax | −78 | 40 | 117 | 483 |
| Tax | −0 | — | −30 | −104 |
| Net profit | −78 | 40 | 87 | 379 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 576 | 1 046 | 1 063 | 1 499 |
| Equity | −53 | −13 | 74 | 453 |
| Long-term debt | 0 | — | — | — |
| Short-term debt | 629 | 1 060 | 989 | 1 046 |
| Total debt | 629 | 1 060 | 989 | 1 046 |
EBITDA margin
11.9%
This company
15.8%
Market median
-25% vs market
20222025
Equity ratio
30.2%
This company
38.2%
Market median
+21% vs market
20222025
Return on equity
83.7%
This company
18.4%
Market median
+355% vs market
20222025
Net profit margin
8.3%
This company
8.1%
Market median
+2% vs market
20222025
Asset turnover
3.04×
This company
1.12×
Market median
+171% vs market
20222025
Debt / equity
2.31×
This company
0.62×
Market median
-273% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-12-01 – 2022-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
OG Chief Auditor | Chief Auditor | 2025 |
HO Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (3) | ||
BR | Audit | 2022 – 2022 |
LA Chief Auditor | Chief Auditor | 2025 – 2025 |
MC | Audit | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NaprapatEliten Norrköping AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bengt Robert Söderlund | Audit | 0 companies |
| Lars Andreas Landin | Chief Auditor | 0 companies |
| Olle Gustav Sollerud | Chief Auditor | 0 companies |
| Hans Olle Beyron Holmertz | Chief Executive Officer | 0 companies |
| My Cecilia Linnea Broomé | Audit | 0 companies |
| Eric Thobias Månsson | Board of Directors | 0 companies |
| Martin Ingemar Gyllix | Chairman | 0 companies |